Peter Fedichev Named Among Business Insider's Rising Stars in Longevity
Peter Fedichev on The Sheekey Science Show: Treating Aging as a Physics Problem
Gero at Davos: Speaking on Aging Biology and AI-Driven Drug Discovery During World Economic Forum Week
Peter Fedichev Presents "Longevity: The Next Drug Category After GLP-1. From Breakthrough Science to Aging Drugs" During JPM Healthcare Week
Nature Portfolio Launches Dedicated Journal Collection on Gerophysics. Recognizing the emerging field Gero's physics-based approach helped define. Gero's Peter Fedichev and Brian Kennedy are among the collection's editors.
Gero Independent Director Brian Kennedy — a leading aging-biology scientist — discussed Gero's physics-based approach on The Peter Attia Podcast
Gero Appoints Longevity Expert Dr. Brian Kennedy to Board of Directors
Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases
Gero Launches ProtoBind-Diff, a Structure-Free AI Foundation Model for Targeted Small Molecule Discovery
Physics-Powered GenAI Biotech Gero Raises $6M to Find Root Causes of Aging and Age-Related Diseases
Inhibitors in bacterial H2S biogenesis targeting antibiotic resistance and tolerance
Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts human lifespan limit
Unsupervised learning of aging principles from longitudinal data
Germline burden of rare damaging variants negatively affects human healthspan and lifespan
Biological age is a universal marker of aging, stress and frailty
A universal transcriptomic signature of age reveals the temporal scaling of Caenorhabditis elegans aging trajectories
Identification of 12 genetic loci associated with human healthspan
Hacking Aging: A Strategy to Use Big Data from Medical Studies to Extend Human Life
Extracting biological age from biomedical data via deep learning: Too much of a good thing?
Strehler-Mildvan is a degenerate manifold of Gompertz fit
Critical dynamics of gene networks is a mechanism behind ageing and Gompertz law
Stability analysis of a model gene network links aging, stress resistance and negligible senescence
Longevity Biotech Gero entered a research collaboration with Pfizer
Reversing Time: Q&A with Peter Fedichev, Founder and CEO of Gero, and Alex Kadet, Chief Business Officer.
The race to find a Coronavirus treatment has one major obstacle: Big pharma
3 stocks striving to fight Coronavirus using power of AI
In brief: Singapore’s biotech startup GERO Raises $2.2M series A
Singapore-Based Gero Raises $2.2Mn in Series A Round
Blackstone is hunting heads and cutting checks as it doubles down on tech
Singapore AI startup bags $2.2m to create a drug that extends human life
Rare “killer” mutations present at birth could be taking years off your life
Inside the unprecedented global race for a Coronavirus cure
AI (Artificial Intelligence) companies that are combating the COVID-19 pandemic
Partner Therapeutics Starts Belgian Clinical Trials of Potential Coronavirus Treatment
Rare, damaging inherited mutations work together to reduce lifespan
There’s no limit to extending human life, according to scientists
5th Age-Related Disease Therapeutics Summit